Skip to main content
main-content

Obesity, diet, & lifestyle interventions


Browse the latest news, expert commentary, and educational content on obesity and lifestyle interventions.


Highlights

03-23-2021 | Semaglutide | News

STEP 4: Long-term treatment needed for full semaglutide benefit

People with obesity continue to lose weight if they remain on semaglutide 2.4 mg after an initial 20 weeks of treatment, but gradually regain it if they switch to placebo, show the STEP 4 findings.

03-23-2021 | Semaglutide | Commentary | Article

STEP 4: Long-term semaglutide treatment combats weight regain

Domenica Rubino discusses the chronicity of obesity, and how STEP 4 demonstrates the need for long-term semaglutide treatment to avoid weight regain (5:59).

03-04-2021 | Semaglutide | Commentary | Article

STEP 2: A higher semaglutide dose in people with type 2 diabetes

Ildiko Lingvay discusses the STEP 2 findings, and why a higher semaglutide dose may be optimal for most people with type 2 diabetes (8:06).

Semaglutide for weight loss: The STEP and SELECT trials

Get the latest results and insights from the researchers.

More on obesity & lifestyle interventions

DiRECT: Type 2 diabetes remission through weight management

Primary findings, 2-year outcomes and translating this landmark trial into practice

Stay informed with Medicine Matters

Get the latest developments in diabetes delivered straight to your inbox

Image Credits